首页> 美国卫生研究院文献>Interdisciplinary Toxicology >Inhibition of nitric oxide production in lipopolysaccharide-activated RAW 264.7 macrophages by Jeju plant extracts
【2h】

Inhibition of nitric oxide production in lipopolysaccharide-activated RAW 264.7 macrophages by Jeju plant extracts

机译:济州植物提取物抑制脂多糖激活的RAW 264.7巨噬细胞中一氧化氮的产生

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nitric oxide (NO) produced in large amounts by inducible nitric oxide synthase (iNOS) is known to be responsible for the vasodilation and hypotension observed during septic shock and inflammation. Thus, inhibitors of iNOS may be useful candidates for the treatment of inflammatory diseases accompanied by the overproduction of NO. In this study, we prepared alcoholic extracts of Jeju plants and screened them for their inhibitory activity against NO production in lipopolysaccharide (LPS)-activated macrophages. Among the 260 kinds of plant extract tested, 122 extracts showed potent inhibitory activity towards NO production by more than 25% at a concentration of 100 µg/mL. Plants such as Malus sieboldii, Vaccinium oldhamii, Corylus hallaisanensis, Carpinus laxiflora, Styrax obassia, and Securinega suffruticosa showed the most potent inhibition (above 70%) at a concentration of 100 µg/mL. The cytotoxic effects of the plant extracts were determined by colorimetric MTT assays and most plant extracts exhibited only moderate cytotoxicity at 100 µg/mL. Therefore, these plants should be considered promising candidates for the further purification of bioactive compounds and would be useful for the treatment of inflammatory diseases accompanying overproduction of NO.
机译:已知由诱导型一氧化氮合酶(iNOS)大量产生的一氧化氮(NO)导致在败血性休克和炎症期间观察到的血管舒张和低血压。因此,iNOS抑制剂可能是治疗炎性疾病并伴随NO过量产生的有用候选药物。在这项研究中,我们制备了济州植物的酒精提取物,并筛选了它们对脂多糖(LPS)活化的巨噬细胞中NO产生的抑制活性。在测试的260种植物提取物中,有122种提取物在浓度为100 µg / mL时对NO产生的抑制作用强于25%。浓度为100 µg / mL的植物,如西伯利亚海棠,越桔越桔,海南榛子,长叶锦鸡儿,欧风菊和白花蛇麻草,表现出最强的抑制作用(超过70%)。植物提取物的细胞毒性作用是通过比色MTT法测定的,大多数植物提取物在100 µg / mL时仅表现出中等的细胞毒性。因此,这些植物应被认为是进一步纯化生物活性化合物的有前途的候选者,将可用于治疗伴随NO过量产生的炎性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号